Demers also extended their thanks and appreciation to Company-1 for its cooperation in the government’s ongoing investigation. “No company with significant business interests in China is immune from the coercive power of the Chinese Communist Party,” stated Assistant Attorney General Demers. For companies with operations in China, like that here, this reality may mean executives being coopted to further repressive activity at odds with the values that have allowed that company to flourish here.” “The Chinese Communist Party will use those within its reach to sap the tree of liberty, stifling free speech in China, the United States and elsewhere about the Party’s repression of the Chinese people. “The FBI remains committed to protecting the exercise of free speech for all Americans. As this complaint alleges, that freedom was directly infringed upon by the pernicious activities of Communist China’s Intelligence Services, in support of a regime that neither reflects nor upholds our democratic values,” stated FBI Director Wray. “Americans should understand that the Chinese Government will not hesitate to exploit companies operating in China to further their international agenda, including repression of free speech.”Īccording to the complaint, Jin served as Company-1’s primary liaison with PRC law enforcement and intelligence services. Sources chinabased keep linkdoc us ipotimes free# In that capacity, he regularly responded to requests from the PRC government for information and to terminate video meetings hosted on Company-1’s video communications platform. Sources chinabased keep linkdoc us ipotimes free#.Sources chinabased keep linkdoc us ipotimes series#.Chinese medical data startup LinkDoc Technology is planning to raise 500 million in an initial public offering (IPO), Bloomberg reported, citing sources. LinkDoc’s IPO delay also comes as regulators in Beijing are planning rule changes that would allow them to block a Chinese company from listing overseas even if the unit selling shares is incorporated outside China, closing a loophole long-used by the country’s technology giants, Bloomberg News reported this week. Reuters reported LinkDoc’s IPO halt earlier Thursday. For the same period, net loss attributable to LinkDoc widened to 135.4 million renminbi (21.17 million) from 61.6 million renminbi a year earlier. LinkDoc Technology 859 followers on LinkedIn. The company’s listing plans come despite the U.S.Ī representative for LinkDoc declined to comment. initial public offering, people familiar with the matter said, the first known company to pull out of a debut after China. We are leading oncology real world big data company from China with the vision of care data and care life. HONG KONG Chinese medical data group LinkDoc Technology Ltd has shelved its listing in the United States to raise up to 211 million following Beijing’s clampdown on overseas listings, according to three sources with direct knowledge of the matter. LinkDoc, founded in 2014, provides cancer focused health-care services built on big data and artificial intelligence, its website shows. The LinkDoc Technology (hereinafter 'LinkDoc') case was compiled as one way to find answers to these questions. LinkDoc’s IPO delay also comes as regulators in Beijing are planning rule changes that would allow them to block a Chinese. Its investors include Alibaba Health Information Technology Ltd., MBK Partners, New Enterprise Associates and Temasek Holdings Pte according to a preliminary filing.Ĭhinese companies have raised about $13 billion through first-time share sales in the U.S. The case examines how LinkDoc, specializing in big data and serving the vertical healthcare industry, found its own answers to these issues and, more specifically, how it identified and entered its target market segment, and. this year, according to data compiled by Bloomberg. HONG KONG (Reuters) -Chinese medical data group LinkDoc Technology Ltd has shelved plans for an IPO in the United States due to Beijing's clampdown on overseas listings by domestic firms, according to three sources with direct knowledge of the matter. listing by a Chinese firm on record, after Alibaba Group Holding Ltd.’s $25 billion blockbuster debut in 2014. It is the first Chinese firm known to have pulled back from IPO plans since China's cybersecurity regulator toughened its approach to oversight.
0 Comments
Leave a Reply. |